{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:51:07Z","timestamp":1776199867512,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s11655-024-3818-1","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T12:15:13Z","timestamp":1733400913000},"page":"394-401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Erzhu Jiedu Decoction Granules in Treating Mid-advanced Hepatitis B Virus-Associated Primary Liver Cancer Patients with Pi (Spleen)-Deficiency and Dampness-Heat Syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"Yang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-yi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-yuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-li","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-bing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"3818_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019;394:1145\u20131158.","journal-title":"Lancet"},{"key":"3818_CR2","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/v14050986","volume":"14","author":"GEM Rizzo","year":"2022","unstructured":"Rizzo GEM, Cabibbo G, Crax\u00ec A. Hepatitis B virus-associated hepatocellular carcinoma. Viruses 2022;14:986.","journal-title":"Viruses"},{"key":"3818_CR3","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/cam4.4551","volume":"11","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zheng J, Hao J, Wang RR, Liu X, Gu P, et al. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Med 2022;11:1310\u20131323.","journal-title":"Cancer Med"},{"key":"3818_CR4","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.3390\/cancers14112798","volume":"14","author":"E Chakraborty","year":"2022","unstructured":"Chakraborty E, Sarkar D. Emerging therapies for hepatocellular carcinoma (HCC). Cancers (Basel) 2022;14:2798.","journal-title":"Cancers (Basel)"},{"key":"3818_CR5","first-page":"277","volume":"36","author":"Bureau of Medical Administration","year":"2020","unstructured":"Bureau of Medical Administration, National Health Commission of the People\u2019s Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition). J Clin Hepatol (Chin) 2020;36:277\u2013292.","journal-title":"J Clin Hepatol (Chin)"},{"key":"3818_CR6","first-page":"101","volume":"27","author":"National Major and Difficult Diseases (Primary Liver Cancer) Clinical Cooperation Group of Traditional Chinese and Western Medicine","year":"2021","unstructured":"National Major and Difficult Diseases (Primary Liver Cancer) Clinical Cooperation Group of Traditional Chinese and Western Medicine. Consensus on diagnosis and treatment of primary liver cancer with integrated traditional Chinese and Western medicine. Guid J Tradit Chin Med Pharm (Chin) 2021;27:101\u2013107.","journal-title":"Guid J Tradit Chin Med Pharm (Chin)"},{"key":"3818_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/imj.14844","volume":"51","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Ni S, Chen YY, Ling QH, Chen JJ. Erzhu Qinggan Jiedu Recipe improves the clinical outcome of hepatocellular cancer after surgical resection: a case-control retrospective study. Int Med J 2021;51:853\u2013860.","journal-title":"Int Med J"},{"key":"3818_CR8","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.7150\/jca.49554","volume":"11","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Chen T, Chen J. Erzhu Jiedu Decoction ameliorates liver precancerous lesions in a rat model of liver cancer. J Cancer 2020;11:7302\u20137311.","journal-title":"J Cancer"},{"key":"3818_CR9","first-page":"208","volume-title":"Guiding principles for clinical research of new traditional Chinese medicine","year":"2002","unstructured":"Zheng XY, ed. Guiding principles for clinical research of new traditional Chinese medicine. Beijing: China Medical Science and Technology Press;2002:208\u2013216."},{"key":"3818_CR10","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1016\/j.ejca.2014.05.024","volume":"50","author":"AG Robinson","year":"2014","unstructured":"Robinson AG, Booth CM, Eisenhauer EA. Progression-free survival as an end-point in solid tumours\u2014perspectives from clinical trials and clinical practice. Eur J Cancer 2014;50:2303\u20132308.","journal-title":"Eur J Cancer"},{"key":"3818_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","volume":"389","author":"J Bruix","year":"2017","unstructured":"Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2017;389:56\u201366.","journal-title":"Lancet"},{"key":"3818_CR12","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W","volume":"53","author":"V Mor","year":"1984","unstructured":"Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky performance status scale. an examination of its reliability and validity in a research setting. Cancer 1984;53:2002\u20132007.","journal-title":"Cancer"},{"key":"3818_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev-med-042220-021121","volume":"73","author":"RC Sperandio","year":"2022","unstructured":"Sperandio RC, Pestana RC, Miyamura BV, Kaseb AO. Hepatocellular carcinoma immunotherapy. Annu Rev Med 2022;73:267\u2013278.","journal-title":"Annu Rev Med"},{"key":"3818_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.gassur.2024.01.042","volume":"28","author":"HA Lima","year":"2024","unstructured":"Lima HA, Mavani P, Munir MM, Endo Y, Woldesenbet S, Khan MMM, et al. Medicaid expansion and palliative care for advanced-stage liver cancer. J Gastrointest Surg 2024;28:434\u2013441.","journal-title":"J Gastrointest Surg"},{"key":"3818_CR15","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1001\/jamaoncol.2019.3338","volume":"5","author":"MJ Raphael","year":"2019","unstructured":"Raphael MJ, Robinson A, Booth CM, O\u2019Donnell J, Palmer M, Eisenhauer E, et al. The value of progression-free survival as a treatment end point among patients with advanced cancer: a systematic review and qualitative assessment of the literature. JAMA Oncol 2019;5:1779\u20131789.","journal-title":"JAMA Oncol"},{"key":"3818_CR16","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1002\/ijc.31957","volume":"144","author":"TJ Hwang","year":"2019","unstructured":"Hwang TJ, Gyawali B. Association between progressionfree survival and patients\u2019 quality of life in cancer clinical trials. Int J Cancer 2019;144:1746\u20131751.","journal-title":"Int J Cancer"},{"key":"3818_CR17","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.3390\/ijms22115801","volume":"22","author":"K Oura","year":"2021","unstructured":"Oura K, Morishita A, Tani J, Masaki T. Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review. Int J Mol Sci 2021;22:5801.","journal-title":"Int J Mol Sci"},{"key":"3818_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2022.02.032","volume":"77","author":"M Barsch","year":"2022","unstructured":"Barsch M, Sali\u00e9 H, Schlaak AE, Zhang Z, Hess M, Mayer LS, et al. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. J Hepatol 2022;77:397\u2013409.","journal-title":"J Hepatol"},{"key":"3818_CR19","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","volume":"29","author":"A Magen","year":"2023","unstructured":"Magen A, Hamon P, Fiaschi N, Soong BY, Park MD, Mattiuz R, et al. Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nat Med 2023;29:1389\u20131399.","journal-title":"Nat Med"},{"key":"3818_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jnci\/djab223","volume":"114","author":"MA Mollica","year":"2022","unstructured":"Mollica MA, Smith AW, Tonorezos E, Castro K, Filipski KK, Guida J, et al. Survivorship for individuals living with advanced and metastatic cancers: national cancer institute meeting report. J Natl Cancer Inst 2022;114:489\u2013495.","journal-title":"J Natl Cancer Inst"},{"key":"3818_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1472-6947-13-72","volume":"13","author":"D P\u00e9us","year":"2013","unstructured":"P\u00e9us D, Newcomb N, Hofer S. Appraisal of the Karnofsky performance status and proposal of a simple algorithmic system for its evaluation. BMC Med Inform Decis Mak 2013;13:72.","journal-title":"BMC Med Inform Decis Mak"},{"key":"3818_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s11655-021-3449-8","volume":"28","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Li JW, Zeng PH, Gao WH, Tian XF. Data mining and systems pharmacology to elucidate effectiveness and mechanisms of Chinese medicine in treating primary liver cancer. Chin J Integr Med 2022;28:636\u2013643.","journal-title":"Chin J Integr Med"},{"key":"3818_CR23","doi-asserted-by":"publisher","first-page":"117893","DOI":"10.1016\/j.jep.2024.117893","volume":"325","author":"F Wang","year":"2024","unstructured":"Wang F, Mai J, Wang H, Xu Y, Zhou X, Xie Z, et al. Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-Q-exactive orbitrap HRMS and network pharmacology. J Ethnopharmacol 2024;325:117893.","journal-title":"J Ethnopharmacol"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-024-3818-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-024-3818-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-024-3818-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T12:06:32Z","timestamp":1746187592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-024-3818-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3818"],"URL":"https:\/\/doi.org\/10.1007\/s11655-024-3818-1","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"29 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None declared.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}